rs1554338834
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_002047.4(GARS1):c.1337A>T(p.Asp446Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.1337A>T | p.Asp446Val | missense_variant | Exon 10 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.1337A>T | p.Asp446Val | missense_variant | Exon 10 of 17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.1235A>T | p.Asp412Val | missense_variant | Exon 9 of 16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.1169A>T | p.Asp390Val | missense_variant | Exon 11 of 18 | ENSP00000502174.1 | ||||
GARS1 | ENST00000675051.1 | c.1136A>T | p.Asp379Val | missense_variant | Exon 10 of 17 | ENSP00000502296.1 | ||||
GARS1 | ENST00000674815.1 | c.968A>T | p.Asp323Val | missense_variant | Exon 10 of 17 | ENSP00000502799.1 | ||||
GARS1 | ENST00000674851.1 | c.968A>T | p.Asp323Val | missense_variant | Exon 11 of 18 | ENSP00000502451.1 | ||||
GARS1 | ENST00000444666.6 | n.1337A>T | non_coding_transcript_exon_variant | Exon 10 of 18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*1051A>T | non_coding_transcript_exon_variant | Exon 11 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*437A>T | non_coding_transcript_exon_variant | Exon 11 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*675A>T | non_coding_transcript_exon_variant | Exon 11 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.1337A>T | non_coding_transcript_exon_variant | Exon 10 of 16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*1207A>T | non_coding_transcript_exon_variant | Exon 11 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.1337A>T | non_coding_transcript_exon_variant | Exon 10 of 15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*1279A>T | non_coding_transcript_exon_variant | Exon 12 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*282A>T | non_coding_transcript_exon_variant | Exon 10 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*788A>T | non_coding_transcript_exon_variant | Exon 10 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*626A>T | non_coding_transcript_exon_variant | Exon 11 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*769A>T | non_coding_transcript_exon_variant | Exon 10 of 17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.1337A>T | non_coding_transcript_exon_variant | Exon 10 of 16 | ENSP00000502681.1 | |||||
GARS1 | ENST00000674616.1 | n.*1051A>T | 3_prime_UTR_variant | Exon 11 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*437A>T | 3_prime_UTR_variant | Exon 11 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*675A>T | 3_prime_UTR_variant | Exon 11 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000675529.1 | n.*1207A>T | 3_prime_UTR_variant | Exon 11 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000676088.1 | n.*1279A>T | 3_prime_UTR_variant | Exon 12 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*282A>T | 3_prime_UTR_variant | Exon 10 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*788A>T | 3_prime_UTR_variant | Exon 10 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*626A>T | 3_prime_UTR_variant | Exon 11 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*769A>T | 3_prime_UTR_variant | Exon 10 of 17 | ENSP00000501980.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Uncertain:1
This sequence change replaces aspartic acid with valine at codon 446 of the GARS protein (p.Asp446Val). The aspartic acid residue is highly conserved and there is a large physicochemical difference between aspartic acid and valine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with GARS-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at